ENTITY
Kolon TissueGene

Kolon TissueGene (950160 KS)

15
Analysis
Health Care • United States
Kolon TissueGene, Inc. operates as a biopharmaceutical company. The Company develops novel advanced orthopedic disorders cell therapies, novel cell and gene therapies drugs, and other related products. Kolon TissueGene offers services worldwide.
more
•19 Feb 2018 10:27

Korean IPOs - Evidence-Based Analysis & The Whiplash Effect

In this report, we provide evidence-based analysis of using key criteria such as the IPO price determined at high/low end of the IPO price range...

Logo
302 Views
Share
•21 Dec 2017 08:14

StubWorld - Set-Up & Unwind Extremes:Ā AVIC, Kolon

This week I briefly look at:Ā Avic International Holdings Ltd (161 HK), again, as investors take-profit while 69.7%-held subsidiaryĀ Shennan Circuits...

Logo
644 Views
Share
•25 Nov 2017 21:53

Summary of KOSDAQ 150 December Reshuffle & Rebalancing

It was officially announced that a total of 13 stocks would be newly added to KOSDAQ 150 in the upcoming periodical reshuffle, whereas the same...

Logo
651 Views
Share
•16 Nov 2017 22:57

KOSDAQ's Bullish Run - Main Drivers & Stocks to Pick

KOSDAQ is getting really hot. Over the past three months, KOSDAQ index climbed 22.89% by 145.31 points from 642.11 on Aug 17 to 780.22 today on Nov...

Logo
728 Views
Share
bearish•CJ ENM
•10 Nov 2017 22:06

CJ E&M Vs. Hanjin Kal - Trade Pattern Analysis Amid Subsidiary IPO

We, Korea, have two major IPOs coming up late this year. They are Studio Dragon Corp (253450 KS) and Jin Air Co., Ltd. (272450 KS). Both are...

Logo
415 Views
Share
x